Mass. biotech companies still raising venture capital

07/7/2008 | Boston Globe (tiered subscription model), The

Biotech companies in Massachusetts continue to gain investments amid a declining stock market and dwindling initial public offerings. Agios Pharmaceuticals, a Boston-based firm working on drugs designed to starve cancerous cells, has secured $33 million in venture capital. Concert Pharmaceuticals and Constellation Pharmaceuticals also each have raised more than $30 million this year.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations